Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

Mattie Lenzen; Eric Boersma; WJM (Wilma) Scholte op Reimer; Aggie Balk; M Komajda; K Swedberg; F Follath; M Jimenez-Navarro; Maarten Simoons; JGF Cleland

doi:10.1093/eurheartj/ehi499

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

Mattie Lenzen, Eric Boersma, WJM (Wilma) Scholte op Reimer, Aggie Balk, M Komajda, K Swedberg, F Follath, M Jimenez-Navarro, Maarten Simoons, JGF Cleland

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

151 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2706-2713
Number of pages	8
Journal	European Heart Journal
Volume	26
Issue number	24
DOIs	https://doi.org/10.1093/eurheartj/ehi499
Publication status	Published - 2005

Access to Document

10.1093/eurheartj/ehi499

http://hdl.handle.net/1765/68058

Cite this

Lenzen, M., Boersma, E., Scholte op Reimer, WJM., Balk, A., Komajda, M., Swedberg, K., Follath, F., Jimenez-Navarro, M., Simoons, M., & Cleland, JGF. (2005). Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. European Heart Journal, 26(24), 2706-2713. https://doi.org/10.1093/eurheartj/ehi499

@article{eb62b1efc2ec447f864ffa0e5e5f3b85,

title = "Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure",

author = "Mattie Lenzen and Eric Boersma and {Scholte op Reimer}, {WJM (Wilma)} and Aggie Balk and M Komajda and K Swedberg and F Follath and M Jimenez-Navarro and Maarten Simoons and JGF Cleland",

year = "2005",

doi = "10.1093/eurheartj/ehi499",

language = "Undefined/Unknown",

volume = "26",

pages = "2706--2713",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "24",

}

Lenzen, M , Boersma, E, Scholte op Reimer, WJM, Balk, A, Komajda, M, Swedberg, K, Follath, F, Jimenez-Navarro, M, Simoons, M & Cleland, JGF 2005, 'Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure', European Heart Journal, vol. 26, no. 24, pp. 2706-2713. https://doi.org/10.1093/eurheartj/ehi499

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. / Lenzen, Mattie ; Boersma, Eric; Scholte op Reimer, WJM (Wilma) et al.
In: European Heart Journal, Vol. 26, No. 24, 2005, p. 2706-2713.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

AU - Lenzen, Mattie

AU - Boersma, Eric

AU - Scholte op Reimer, WJM (Wilma)

AU - Balk, Aggie

AU - Komajda, M

AU - Swedberg, K

AU - Follath, F

AU - Jimenez-Navarro, M

AU - Simoons, Maarten

AU - Cleland, JGF

PY - 2005

Y1 - 2005

U2 - 10.1093/eurheartj/ehi499

DO - 10.1093/eurheartj/ehi499

M3 - Article

SN - 0195-668X

VL - 26

SP - 2706

EP - 2713

JO - European Heart Journal

JF - European Heart Journal

IS - 24

ER -

Lenzen M , Boersma E, Scholte op Reimer WJM, Balk A, Komajda M, Swedberg K et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. European Heart Journal. 2005;26(24):2706-2713. doi: 10.1093/eurheartj/ehi499